In a meta-analysis including 12 articles with a total of 1596 individuals diagnosed with CAD and 1431 individuals in the control group, no significant relationship was found between Apolipoprotein B gene polymorphism and CAD risk [24]. The gene discussed is APOB; the disease is coronary artery disorder.